As of 2025-09-18, the EV/EBITDA ratio of EyePoint Pharmaceuticals Inc (EYPT) is -4.64. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. EYPT's latest enterprise value is 869.06 mil USD. EYPT's TTM EBITDA according to its financial statements is -187.14 mil USD. Dividing these 2 quantities gives us the above EYPT EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 6.8x - 10.8x | 7.6x |
| Forward P/E multiples | 12.1x - 17.4x | 14.6x |
| Fair Price | (31.71) - (28.34) | (29.10) |
| Upside | -332.5% - -307.8% | -313.4% |
| Date | EV/EBITDA |
| 2025-09-16 | -4.63 |
| 2025-09-15 | -4.56 |
| 2025-09-12 | -4.54 |
| 2025-09-11 | -4.53 |
| 2025-09-10 | -4.61 |
| 2025-09-09 | -4.85 |
| 2025-09-08 | -4.65 |
| 2025-09-05 | -4.78 |
| 2025-09-04 | -4.00 |
| 2025-09-03 | -4.04 |
| 2025-09-02 | -3.94 |
| 2025-08-29 | -3.88 |
| 2025-08-28 | -3.89 |
| 2025-08-27 | -3.98 |
| 2025-08-26 | -4.05 |
| 2025-08-25 | -3.89 |
| 2025-08-22 | -3.98 |
| 2025-08-21 | -3.89 |
| 2025-08-20 | -3.86 |
| 2025-08-19 | -3.69 |
| 2025-08-18 | -3.79 |
| 2025-08-15 | -3.70 |
| 2025-08-14 | -3.62 |
| 2025-08-13 | -3.68 |
| 2025-08-12 | -3.58 |
| 2025-08-11 | -3.40 |
| 2025-08-08 | -3.39 |
| 2025-08-07 | -3.33 |
| 2025-08-06 | -3.52 |
| 2025-08-05 | -3.63 |
| 2025-08-04 | -3.33 |
| 2025-08-01 | -3.20 |
| 2025-07-31 | -3.24 |
| 2025-07-30 | -3.24 |
| 2025-07-29 | -3.25 |
| 2025-07-28 | -3.31 |
| 2025-07-25 | -3.48 |
| 2025-07-24 | -3.48 |
| 2025-07-23 | -3.56 |
| 2025-07-22 | -3.47 |
| 2025-07-21 | -3.50 |
| 2025-07-18 | -3.46 |
| 2025-07-17 | -3.41 |
| 2025-07-16 | -3.33 |
| 2025-07-15 | -3.24 |
| 2025-07-14 | -3.37 |
| 2025-07-11 | -3.44 |
| 2025-07-10 | -3.69 |
| 2025-07-09 | -3.66 |
| 2025-07-08 | -3.28 |